Nutra Pharma Corp. Reaches Settlement with SEC
22 mars 2024 16h39 HE
|
Nutra Pharma Corp.
Nutra Pharma Corp. Reaches Settlement with SEC
Nutra Pharma Announces First Manufacturing Agreement
23 mars 2022 09h15 HE
|
Nutra Pharma Corp.
Plantation, Florida, March 23, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
Nutra Pharma Expands Manufacturing Capabilities
17 mars 2022 09h15 HE
|
Nutra Pharma Corp.
Plantation, Florida, March 17, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
Nutra Pharma Letter to Shareholders
18 janv. 2022 12h44 HE
|
Nutra Pharma Corp.
Plantation, Florida, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Nutra Pharma Provides Business and Compliance Updates
26 juil. 2021 10h30 HE
|
Nutra Pharma Corp.
Plantation, Florida, July 26, 2021 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures
23 juil. 2021 09h14 HE
|
Nutra Pharma Corp.
Plantation, Florida , July 23, 2021 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Nutra Pharma Engages Government Affairs Consulting Firm
15 juil. 2021 08h30 HE
|
Nutra Pharma Corp.
Plantation, Florida, July 15, 2021 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in...
Nutra Pharma Announces that Nyloxin is Now Available on the iRemedy Marketplace
30 mai 2019 08h30 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., May 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter...
Nutra Pharma Responds to FDA Warning Letter
10 avr. 2019 08h30 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., April 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the...
Nutra Pharma Comments on SEC Complaint
28 sept. 2018 17h58 HE
|
Nutra Pharma Corp.
Nutra Pharma is providing comments on the SEC Complaint filed against Nutra Pharma, its CEO and a Consultant to the company. CORAL SPRINGS, Fla., Sept. 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE...